Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices

REFERENCES

• Brachman P. S., Kaufmann A. F. Anthrax. Bacterial Infections of Humans, A. S. Evans, P. S. Brachman. Plenum Medical Book Company, , New York 1998; 95–111
   Google Scholar
• Koch R. The Aetiology of Anthrax Based on the Ontogeny of the AnthraxBacillus. Med. Classics 1937; 2: 787
   Google Scholar
• Bell J. H. On Anthrax and Athracaemia in Wool Sorters, Heifers, and Sheep. BMJ 1880; 2: 56–61
   Google Scholar
• Davies J. C.A. A Major Epidemic of Anthrax in Zimbabwe. Cent. Afr. J. Med. 1982; 28: 291–298
   PubMedGoogle Scholar
• Van Ness G. B. Ecology of Anthrax. Science 1971; 172: 1303–1307
   PubMed Web of Science ®Google Scholar
• Turnbull P. C.B. Guidelines for the Surveillance and Control of Anthrax in Humansand Animals. Geneva, Switzerland: World Health Organization, Department ofCommunicable Diseases Surveillance and Response. 1998, publicationno. WHO/EMC/ZDI/98.6.
   Google Scholar
• Brachman P. Inhalation Anthrax. Ann. N. Y. Acad. Sci. 1980; 353: 83–93
   PubMedGoogle Scholar
• Brachman P. S., Friedlander A. M. Anthrax. Vaccines, S. A. Plotkin, E. A. Mortimer. 2nd Ed., WB Saunders Company, Philadelphia, PA 1994; 729–739
   Google Scholar
• Whitford H. W. Incidence of Anthrax in the USA: 1945–1988. Salisbury Medical Bulletin April 11–13, 1989; 68(suppl): 5–7
   Google Scholar
• CDC. Surveillance for Adverse Events Associated with AnthraxVaccination—US Department of Defense, 1998–2000. MMWR 2000; 49: 341–345
   PubMedGoogle Scholar
• Pile J. C., Malone J. D., Eitzen E. M., Friedlander A. M. Anthrax as a Potential Biological Warfare Agent. Arch. Intern. Med. 1998; 158: 429–434
   PubMed Web of Science ®Google Scholar
• Inglesby T. V., Henderson D. A., Bartlett J. G., Ascher M. S., Eitzen E., Friedlander A. M., Hauer J., McDade J., Osterholm M. T., O'Toole T., Parker G., Perl T. M., Russell P. K., Tonat K. Anthrax as a Biological Weapon. JAMA 1999; 281: 1735–1745
   PubMed Web of Science ®Google Scholar
• Christopher G. W., Cieslak T. J., Pavlin J. A., Eitzen E. M., Jr. Biological Warfare: A Historical Perspective. JAMA 1997; 278: 412–417
   PubMed Web of Science ®Google Scholar
• Franz D. R., Jahrling P. B., Friedlander A. M., McClain D. J., Hoover D. L., Bryne W. R., Pavlin J. A., Christopher G. W., Eitzen E. M. Jr. Clinical Recognition and Management of Patients Exposed to BiologicalWarfare Agents. JAMA 1997; 278: 399–411
   PubMed Web of Science ®Google Scholar
• World Health Organization. Health Aspects of Chemical and Biological Weapons: A Report ofa WHO Group of Consultants. World Health Organization, GenevaSwitzerland 1970
   Google Scholar
• Jemski J. V. Respiratory Virulence of Pasteurella tularensis Schu S4 strain,for Man, Monkey and Guinea Pig. April 15, 1963, DTICrecovery no. AD 498-288
   Google Scholar
• Albrink W. S., Goodlow R. J. Experimental Inhalation Anthrax in the Chimpanzee. Am. J. Pathol. 1959; 35: 1055–1065
   PubMed Web of Science ®Google Scholar
• Dolan J. E., Sanders W. M., III. Interim Report 113: BW Vulnerability Study of the Hazards toPersonnel Caused by the Operation of a Helicopter on Contaminated Terrain.Frederick, MD: Army Biological Labs. November 1955, DTICrecovery no. AD 222-773
   Google Scholar
• Carpenter R. T., Dahlgren C. M. Interim Report 79: BW Vulnerability Study of the Hazards Dueto Secondary Aerosols from Contaminated Terrain. Frederick, MD: Army BiologicalLabs. October 1954, DTICrecovery no. AD 262-871
   Google Scholar
• Chinn K. S.K, Adams D. J. Hazard Assessment for Suspension of Agent-Contaminated Soil.Washington, DC: US Department of Defense. October 1990, DPGdocument no. DPG/JOD-91/002
   Google Scholar
• Patrick W. C., III. Risk Assessment of Biological Warfare Primary and SecondaryAerosols and Their Requirements for Decontamination. Vienna, VA: Science ApplicationsInternational Corporation. 1999
   Google Scholar
• Abdenour D., Larouze B., Dalichaouche M., Aouati M. Familial Occurrence of Anthrax in Eastern Algeria. J. Infect. Dis. 1987; 155: 1083–1084
   PubMed Web of Science ®Google Scholar
• Anonymous. Report of the Departmental Committee Appointed to Inquire as toPrecautions for Preventing Danger of Infection from Anthrax in the Manipulationof Wool, Goat Hair, and Camel Hair. Summary of Evidence and Appendices. His Majesty'sStationery Office, London, England 1918; III: 116–118
   Google Scholar
• Dixon T. C., Meselson M., Guillemin J., Hanna P. C. Anthrax. N. Engl. J. Med. 1999; 341: 815–826
   PubMed Web of Science ®Google Scholar
• Tekin A., Bulut N., Unal T. Acute Abdomen Due to Anthrax. Br. J. Surg. 1997; 84: 813
   PubMed Web of Science ®Google Scholar
• Jena G. P. Intestinal Anthrax in Man: A Case Report. Centr. Afr. J. Med. 1980; 26: 253–254
   PubMedGoogle Scholar
• Ndyabahinduka D. G.K, Chu I. H., Abdou A. H., Gaifuba J. K. An Outbreak of Human Gastrointestinal Anthrax. Ann. Ist. Super Sanita. 1984; 20: 205–208
   PubMedGoogle Scholar
• Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokov A., Yampolskaya O. The Sverdlovsk Anthrax Outbreak of 1979. Science 1994; 266: 1202–1207
   PubMed Web of Science ®Google Scholar
• Brachman P. S., Plotkin S. A., Bumford F. H., Atchison M. M. An Epidemic of Inhalation Anthrax: The First in the TwentiethCentury. II. Epidemiology. Am. J. Hyg. 1960; 72: 6–23
   PubMed Web of Science ®Google Scholar
• Henderson D. W., Peacock S., Belton F. C. Observations on the Prophylaxis of Experimental Pulmonary Anthraxin the Monkey. J. Hyg. 1956; 54: 28–36
   PubMedGoogle Scholar
• Gleiser C. A., Berdjis C. C., Hartman H. A., Grochenour W. S. Pathology of Experimental Respiratory Anthrax in Macaca mulatta. Brit. J. Expt. Path. 1963; 44: 416–426
   PubMed Web of Science ®Google Scholar
• Hambleton P., Carman J. A., Melling J. Anthrax: The Disease in Relation to Vaccines. Vaccine 1984; 2: 125–132
   PubMedGoogle Scholar
• Friedlander A. M. Anthrax. Textbook of Military Medicine: Medical Aspects of Chemical andBiological Warfare, Part 1., F. R. Sidell, E. T. Takafuji, D. R. Franz. Walter Reed Army Medical Center, Washington, DC, 467–478
   Google Scholar
• Mikesell P., Ivins B. E., Ristroph J. D., Dreier T. M. Evidence for Plasmid-Mediated Toxin Production in Bacillus anthracis. Infect. Immun. 1983; 39: 371–376
   PubMed Web of Science ®Google Scholar
• Lincoln R. E., Fish D. C. Anthrax Toxin. Microbial Toxins., T. Montie, S. Kadis, S. J. Ajl. Academic Press, Inc., , New York, 316–414
   Google Scholar
• Duesbery N. S., Webb C. P., Leppla S. H., Gordon V. M., Klimpel K. R., Copeland T. D., Ahn N. G., Oskarsson M. K., Fukasawa K., Paull K. D., Vande Woude G. F. Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax LethalFactor. Science 1998; 280: 734–735
   PubMed Web of Science ®Google Scholar
• Farrar W. E. Anthrax: Virulence and Vaccines. Ann. Intern. Med. 1994; 121: 379
   PubMed Web of Science ®Google Scholar
• Fox J. Bioterrorism: Microbiology Key to Dealing with Threats [Letter]. ASM News May 1998; 64: 225–227
   Google Scholar
• Milne J. C., Furlong D., Hanna P. C., Wall J. S., Collier R. J. Anthrax Protective Antigen Forms Oligomers During Intoxicationof Mammalian Cells. J. Biol. Chem. 1994; 267: 20607–20612
   Google Scholar
• Hanna P. How Anthrax Kills. Science 1998; 280: 1671–1673
   PubMed Web of Science ®Google Scholar
• Pasteur L. On the Attenuation of Viruses and on it's Return to Virulence[French]. C. R. Acad. Sci. 1881; 101: 429–435
   Google Scholar
• Greenfield W. S. Lectures on Some Recent Investigations into the Pathology ofInfective and Contagious Diseases. Lecture III; Part I. Anthrax and AnthracoidDiseases. Lancet 1880; 1: 865–867
   Google Scholar
• Sterne M. The Use of Anthrax Vaccines Prepared from Avirulent (Unencapsulated)Variants of Bacillus anthracis. Onderstepoort J. Vet. Sci. An. Ind. 1939; 13: 307–312
   Google Scholar
• Sterne M. The Immunization of Laboratory Animals Against Anthrax. J. S. Afr. Vet. Med. Assoc. 1942; 13: 53–57
   Google Scholar
• Bail O. Research into Natural and Artificial Anthrax Immunity [German]. Zentralb. Bakteriol. Parasitenk. Infectionskr. 1904; 47: 270–272
   Google Scholar
• Salsbery C. E. Anthrax Aggressin. J. Am. Vet. Med. Assoc. 1926; 68: 755–757
   Google Scholar
• Gladstone G. P. Immunity to Anthrax: Protective Antigen Present in Cell-FreeCulture Filtrates. Br. J. Exp. Pathol. 1946; 27: 394–418
   PubMed Web of Science ®Google Scholar
• Belton F. C., Strange R. E. Studies on a Protective Antigen Produced in Vitro from Bacillusanthracis: Medium and Methods of Production. Br. J. Exp. Pathol. 1954; 35: 144–149
   PubMed Web of Science ®Google Scholar
• Mahlandt B. G., Klein F., Lincoln R. E., Haines B. W., Jones W. I., Jr., Friedman R. H. Immunologic Studies of Anthrax: IV. Evaluation of the Immunogenicityof Three Components of Anthrax Toxin. J. Immunol. 1966; 96: 727–733
   PubMed Web of Science ®Google Scholar
• Puziss M., Manning L. C., Lynch J. W., Barclay E., Abelow I., Wright G. G. Large-Scale Production of Protective Antigen of Bacillus anthracisin Aerobic Cultures. Appl. Microbiol. 1963; 11: 330–334
   PubMedGoogle Scholar
• Puziss M., Wright G. G. Studies on Immunity in Anthrax. X. Gel-Adsorbed Protective Antigenfor Immunization in Man. J. Bacteriol. 1963; 85: 230–236
   PubMed Web of Science ®Google Scholar
• Wright G. G., Green T. W., Kanode R. G., Jr. Studies on Immunity in Anthrax. V. Immunizing Activity of Alum-PrecipitatedProtective Antigen. J. Immunol. 1954; 73: 387–391
   PubMed Web of Science ®Google Scholar
• Tresselt H. B., Boor A. K. An Antigen Prepared in Vitro Effective for Immunization AgainstAnthrax. III. Immunisation of Monkeys Against Anthrax. J. Infect. Dis. 1954; 96: 207–302
   Google Scholar
• Little S. F., Ivins B. E., Fellows P. F., Friedlander A. M. Passive Protection by Polyclonal Antibodies Against Bacillusanthracis Infection in Guinea Pigs. Infect. Immun. 1997; 65: 5171–5175
   PubMed Web of Science ®Google Scholar
• Pitt M. L.M, Little S., Ivins B. E., Fellows P., Boles J., Barth J., Hewetson J., Friedlander A. M. In vitro Correlate of Immunity in an Animal Model of InhalationalAnthrax. J. Appl. Microbiol. 1999; 87: 304
   PubMed Web of Science ®Google Scholar
• Fowler K., McBride B. W., Turnbull P. C.B, Baillie L. W.J. Immune Correlates of Protection Against Anthrax. J. Appl. Microbiol. 1999; 87: 305
   Google Scholar
• Turnbull P. C.B, Broster M. G., Carman J. A., Manchee R. J., Melling J. Development of Antibodies to Protective Antigen and Lethal FactorComponents of Anthrax Toxin in Humans and Guinea Pigs and Their Relevanceto Protective Immunity. Infect. Immun. 1986; 52: 356–363
   PubMed Web of Science ®Google Scholar
• Beall F. A., Taylor M. J., Thorne C. B. Rapid Lethal Effect in Rats of a Third Component Found UponFractionating the Toxin Bacillus anthracis. J. Bacteriol. 1962; 83: 1274–1280
   PubMed Web of Science ®Google Scholar
• Harrison L. H., Ezzell J. W. Veterinary Laboratory Investigation Center; Abshire, T.G.; Kidd,S.; Kaufmann, A.F. Evaluation of Serologic Tests for Diagnosis of AnthraxAfter an Outbreak of Cutaneous Anthrax in Paraguay. J. Infect. Dis. 1989; 160: 706–710
   PubMed Web of Science ®Google Scholar
• Advisory Committee for Immunization Practices. Adult Immunization. MMWR 1984; 33: 33–34
   Google Scholar
• 21CFR 620.23.
   Google Scholar
• Darlow H. M., Belton F. C., Henderson D. W. The Use of Anthrax Antigen to Immunise Man and Monkey. Lancet (September 8)1956; 476–479
   PubMed Web of Science ®Google Scholar
• Turnbull P. C.B. Anthrax Vaccines: Past, Present and Future. Vaccine 1991; 9: 533–539
   PubMed Web of Science ®Google Scholar
• Brachman P. S., Gold H., Plotkin S. A., Fekety F. R., Werrin M., Ingraham N. R. Field Evaluation of a Human Anthrax Vaccine. Am. J. Public Health 1962; 52: 632–645
   PubMed Web of Science ®Google Scholar
• Johnson-Winegar A. Comparison of Enzyme-Linked Immunosorbent and Indirect HemagglutinationAssays for Determining Anthrax Antibodies. J. Clin. Microbiol. 1984; 20: 357–361
   PubMed Web of Science ®Google Scholar
• Ivins B. E., Ezzell J. W., Jr., Jemski J., Hedlund K. W., Ristroph J. D., Leppla S. H. Immunization Studies with Attenuated Strains of Bacillus anthracis. Infect. Immun. 1986; 52: 454–548
   PubMed Web of Science ®Google Scholar
• Auerbach S., Wright G. G. Studies on Immunity in Anthrax. VI. Immunizing Activity of ProtectiveAntigen Against Various Strains of Bacillus anthracis. J. Immunol. 1955; 75: 129–133
   PubMed Web of Science ®Google Scholar
• Little S. F., Knudson G. B. Comparative Efficacy of Bacillus anthracis Live Spore Vaccineand Protective Antigen Vaccine Against Anthrax in the Guinea Pig. Infect. Immun. 1986; 52: 509–512
   PubMed Web of Science ®Google Scholar
• Ward M. K., McGann V. G., Hogge A. L., Jr., Huff M. L., Kanode R. G., Jr., Roberts E. O. Studies on Anthrax Infections in Immunized Guinea Pigs. J. Infect. Dis. 1965; 115: 59–67
   PubMed Web of Science ®Google Scholar
• Ivins B. E., Fellows P. F., Pitt M. L.M, et al. Efficacy of a Standard Human Anthrax Vaccine Against Bacillusanthracis Aerosol Spore Challenge in Rhesus Monkeys. Salisbury Medical Bulletin (September 19–21) 1995; 87(suppl)125–126
   Google Scholar
• Pitt M. L.M, Ivins B. E., Estep J. E., Farchaus J., Friedlander A. M. Comparison of the Efficacy of Purified Protective Antigen andMDPH [AVA] to Protect Nonhuman Primates from Inhalation Anthrax. Salisbury Medical Bulletin (September 19–21) 1995; 87(suppl)130
   Google Scholar
• Ivins B. E., Pitt M. L.M, Fellows P. F., Farchaus J. W., Benner G. E., Waag D. M., Little S. F., Anderson G. W., Jr., Gibbs P. H., Friedlander A. M. Comparative Efficacy of Experimental Anthrax Vaccine CandidatesAgainst Inhalation Anthrax in Rhesus Macaques. Vaccine 1998; 16: 1141–1148
   PubMed Web of Science ®Google Scholar
• Friedlander A. M., Pittman P. R., Parker G. W. Anthrax Vaccine: Evidence for Safety and Efficacy Against InhalationalAnthrax. JAMA 1999; 282: 2104–2106
   PubMed Web of Science ®Google Scholar
• National Communicable Disease Center. Investigational new drugapplication for anthrax protective antigen, aluminum hydroxide adsorbed. FDA no. DBS-IND 180, 1970
   Google Scholar
• Chen R. T., Rastogi S. C., Mullen J. R., Hayes S. W., Cochi S. L., Donlon J. A., Wassilak S. G. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994; 12: 542–550
   PubMed Web of Science ®Google Scholar
• Committee on Health Effects Associated with Exposures During the Gulf War, Institute of Medicine. Gulf War and Health. Volume I: Depleted Uranium, Sarin, PyridostigmineBromide, and Vaccines, C. E. Fulco, C. T. Liverman, H. C. Sox. NationalAcademy of Sciences, Washington, DC 2000, Available at <http://www.nap.edu/>.Accessed October 23, 2000.
   Google Scholar
• Peeler R. N., Kadull P. J., Cluff L. E. Intensive Immunization of Man: Evaluation of Possible AdverseConsequences. Ann. Intern. Med. 1965; 63: 44–57
   PubMed Web of Science ®Google Scholar
• White C. S., III, Adler W. H., McGann V. G. Repeated Immunization: Possible Adverse Effects—Reevaluationof Human Subjects at 25 Years. Ann. Intern. Med. 1974; 81: 594–600
   PubMed Web of Science ®Google Scholar
• Fukuda K., Nisenbaum R., Stewart G., Thompson W. W., Robin L., Washko R. M., Noah D. L., Barrett D. H., Randall B., Herwaldt B. L., Mawle A. C., Reeves W. C. Chronic Multisymptom Illness Affecting Air Force Veterans ofthe Gulf War. JAMA 1998; 280: 981–988
   PubMed Web of Science ®Google Scholar
• Iowa Persian Gulf Study Group. Self-Reported Illness and HealthStatus Among Gulf War Veterans: A Population-Based Study. JAMA 1997; 277: 238–245
   PubMed Web of Science ®Google Scholar
• CDC/National Institutes of Health. Biosafety in microbiologicaland biomedical laboratories. 4th ed. Washington, DC: US Department of Healthand Human Services, CDC/National Institutes of Health. 2000; 88–89
   Google Scholar
• 9CFR Part 95.
   Google Scholar
• CDC. Bioterrorism Alleging Use of Anthrax and Interim Guidelinesfor Management—United States, 1998. MMWR 1999; 48: 69–74
   PubMedGoogle Scholar
• Barnes J. M. Penicillin and B. anthracis. J. Path. Bact. 1947; 194: 113–125
   Google Scholar
• Doanay M., Aydin N. Antimicrobial Susceptibility of Bacillus anthracis. Scand. J. Infect. Dis. 1991; 23: 333–335
   PubMed Web of Science ®Google Scholar
• Lightfoot N. F., Scott R. J.D, Turnbull P. C.B. Antimicrobial Susceptibility of Bacillus anthracis. Salisbury Med. Bull. (April 11–13) 1990; 68(suppl)95–98
   Google Scholar
• Friedlander A. M., Welkos S. L., Pitt M. L.M, Ezzell J. W., Worsham P. L., Rose K. J., Ivins B. E., Lowe J. R., Howe G. B., Mikesell P., et al. Postexposure Prophylaxis Against Experimental Inhalation Anthrax. J. Infect. Dis. 1993; 167: 1239–1242
   PubMed Web of Science ®Google Scholar